| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |